Anthropic Enters Drug Discovery a Day After IPO Filing, Sparking Competing-With-Customers Debate
IgorCarron · x · 2026-10-28
- Hesamation: just one day after filing for IPO, Anthropic announced it is getting into drug discovery itself.
- The company selling tokens to the pharma industry may end up competing with its own customers.
- Igor Carron draws the broader lesson: companies handing proprietary know-how to AI vendors are 'literally giving away their know-how' — a warning few firms internalize.
More from Companies & People
- Economist Bharat Chandar named Research Director for AI Economics at DigEconLab — soumitrashukla9 · 2026-10-28
- AI support cuts keep getting reversed: Gartner's 14% self-service success rate explains why — Nir777 · 2026-10-28
- Peter Diamandis: Only Founders Obsessed With a Problem for a Decade Should Start Companies — PeterDiamandis · 2026-10-28
- Anthropic Acquires One-Person Biotech Startup That Used Claude to Coordinate 11 Labs — Polymarket · 2026-10-28
- Computer scientist on being interviewed by an "AI Reporter": honesty made it fine — fortnow · 2026-10-28
- Google brings Gemini Robotics ER 2 embodied reasoning model to Google Cloud — ZoubinGhahrama1 · 2026-10-28